Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Clin Trials. 2016 Aug 11;14(1):103–108. doi: 10.1177/1740774516663461

Recruitment methods in a clinical trial of provoked vulvodynia: predictors of enrollment

Candi C Bachour 1, Gloria A Bachmann 2, David C Foster 3, Jim Y Wan 4, Leslie A Rawlinson 1, Candace S Brown 1; Gabapentin Study Group (GABAgroup)
PMCID: PMC5290291  NIHMSID: NIHMS804726  PMID: 27488223

Abstract

Background

Successful recruitment in clinical trials for chronic pain conditions is challenging, especially in women with provoked vulvodynia due to reluctance in discussing pain associated with sexual intercourse. The most successful recruitment methods and the characteristics of women reached with these methods are unknown.

Objective

To compare the effectiveness and efficiency of four recruitment methods and to determine socioeconomic predictors for successful enrollment in a National Institute of Health (NIH)-sponsored multicenter clinical trial evaluating a gabapentin intervention in women with provoked vulvodynia.

Methods

Recruitment methods utilized mass mailing, media, clinician referrals and community outreach. Effectiveness (number of participants enrolled) and efficiency (proportion screened who enrolled) were determined. Socioeconomic variables including race, educational level, annual household income, relationship status, age, menopausal status and employment status also were evaluated regarding which recruitment strategies were best at targeting specific cohorts.

Results

Of 868 potential study participants, 219 were enrolled. The most effective recruitment method in enrolling participants was mass mailing (P<.001). There were no statistically significant differences in efficiency between recruitment methods (P = 0.11). Relative to clinician referral, black women were 13 times as likely to be enrolled through mass mailing (adjusted odds ratio [αOR] 12.5, 95% confidence interval [CI], 3.6 – 43.1) as white women. There were no differences in enrollment according to educational level, annual income, relationship status, age, menopausal status, or employment status and recruitment method.

Conclusion

In this clinical trial, mass mailing was the most effective recruitment method. Race of participants enrolled in a provoked vulvodynia trial was related to the recruitment method.

Keywords: Recruitment methods, predictors, provoked vulvodynia

Background

Clinical trials for chronic pain conditions, often do not meet recruitment goals due to many reasons, including reluctance of subjects to enroll in these trials. Limited recruitment strategies can potentially lead to a highly selective enrollment process, especially if there is a placebo arm and potential subjects are reluctant to go off of pain medication.1 Recruitment of women with provoked vulvodynia is particularly challenging not only due to a placebo arm in most of these studies, but also due to the reluctance in women and clinicians in discussing this condition and the sexual issues, such as dyspareunia, that result.

Successful recruitment methods are often gauged by whether they are effective (meet enrollment goals), efficient (low screened/enrollment ratio), and reach the intended target population. If a recruitment method results in a large pool of candidates, but many are not eligible and enroll, then this approach may not be efficient. Of particular importance in vulvodynia clinical trials is the aim to recruit women with different subtypes, including those from different socioeconomic backgrounds, in order to better characterize the disorder and to determine differences in treatment responsivity.2 Although these indicators of successful recruitment are instrumental for timely completion of clinical trials, they have not been investigated in vulvodynia.

Many clinical trials in vulvodynia have used clinician referrals as the only recruitment method,310 where potential participants are readily available and may be enrolled within a brief period of time with minimal resource requirements. However, this recruitment method may reach a limited population and be susceptible to selection bias as these participants may have better access to health care due to socioeconomic factors or have more complex or severe conditions.11

Studies have shown that clinician-referred participants tend to be white, better educated, more likely to be in a partnered relationship and younger than those in the wider population,11 and a similar demographic profile has been observed in randomized clinical trials in women with vulvodynia.310,1215 Whether these characteristics are related to the recruitment method, or are a true reflection of the patient population deserves study, as epidemiological studies have shown that menopausal women, those of Hispanic descent and those of the black race also report symptoms of vulvodynia.1618

Mass mailing and the media are other common recruitment methods that reach a more representative population and may target groups of interest through use of zip codes and radio and television stations that reach certain subpopulations. However, use of a “broad net” to enroll potential participants may be less efficient. Community outreach has been shown to be highly effective in recruiting minority participants,19 but may be limited by time commitment of investigators and staff.

Since no recruitment method satisfies all criteria for global representation of subjects, there is a trend to actively use more than one recruitment method.1215,20 However, the success of multiple recruitment strategies in meeting recruitment goals has not been reported. We compared the effectiveness and efficiency of clinician referrals, mass mailing, media and community outreach recruitment methods and determined socioeconomic predictors of enrollment for each of these recruitment methods in a National of Institute (NIH)-sponsored multicenter clinical trial evaluating women with vulvodynia.

Methods

Women were recruited for a multicenter clinical trial studying the therapeutic effect of gabapentin, the results of which will be reported at a later date. Institutional review board approval was obtained from the from the University of Rochester School of Medicine and Dentistry, Rutgers-Robert Wood Johnson Medical School and the University of Tennessee Health Science Center, and all subjects signed an informed consent before participation.

Recruitment methods

Recruitment took place from 1 August 2011 through 31 July 2015. Recruitment methods were categorized into 4 main categories according to those used in previous studies: mass mailing, media, clinician referrals and community outreach.21

Clinician referral

Each of the investigators recruited potential participants from their practice and through chart review. In addition, letters containing brochures and a 4” × 4” card containing inclusion/exclusion criteria were mailed to obstetrician-gynecologists and family practice physicians in the community.

Mass mailing

A paid advertisement was placed in a monthly utility bill within a 15-mile radius of the research site at the University of Tennessee Health Science Center, and direct mail advertising at the other research sites within the same 15-mile radius. Specific zip codes from a mailing house were selected for target populations according to age, educational status, and annual household income and race at all three study sites.

Media

Media included fliers and printed advertisements, local newspapers and magazines, the National Vulvodynia Association newsletter, 30-minute spots in local radio stations, website advertisements placed on clinicaltrials.gov, craiglist.com, nva.org, Facebook and university home pages, and the development of a website.

Community outreach

Investigators contacted community leaders and organizations and gave presentations at grand rounds, professional meetings and community events. Research staff set up tables and booths at local events and health screenings.

Terminology

Effectiveness was defined as the number of participants who enrolled. Efficiency was defined as the proportion of those screened who enrolled in the study (signed informed consent), or the “recruitment fraction.”1

Participants

Participants were screened through an online screening questionnaire developed for the research study and through a toll-free telephone number where research staff used the same screening questionnaire to determine eligibility.

Eligible participants were 18 years of age or older and had greater than three continuous months of insertional dyspareunia, pain to touch, or both with tampon insertion (modified `Friedrich's Criteria').22 They were required to demonstrate moderate to severe tenderness in the vulvar vestibule, which was greater than the score in the outer vulvar area or the score in the vagina on the cotton swab test23 during the pelvic examination and report an average pain level of 4 or greater (0, no pain to 10 worse pain imaginable) with two tampon insertions during a two-week screening period.24 They were excluded from study participation if they had other vulvar conditions, including dermatoses, vulvitis, atrophic vaginitis or active vaginal infection, a prior vestibulectomy, were pregnant or at risk for pregnancy without use of a reliable birth control method, had any unstable medical or psychiatric condition, or use of centrally acting antidepressant or anxiolytic medications, with the exception of the long term, stable dose use of selective serotonin reuptake inhibitors.

Participants who were eligible for enrollment completed a 72-item self-report questionnaire.25 The questionnaire included items assessing the women's demographic characteristics, including race, ethnicity, educational level, annual household income, relationship status, age, menopausal status and employment status.

Data analysis

Data were analyzed used SAS version 9.3 (SAS Institute Inc., Cary, North Carolina). Chi-square tests were used to assess differences between the four recruitment methods in effectiveness and efficiency and to assess differences between each of the recruitment methods and the demographic variables. Multinomial logistic regression was then used to fit the data, using demographic variables to describe the likelihood of those enrolled through different recruitment methods, clinician referral being the reference level.26 The significance level was set at 0.01 to account for multiple adjustments.

Results

Data from the community outreach recruitment method was excluded from statistical analyses because only one community outreach-derived participant was screened and none enrolled. We were also unable to analyze data by ethnicity based upon self-reported Hispanic ethnicity being limited to three study participants.

Among 868 potential participants screened, 303 were eligible and 219 were enrolled. The average age of enrolled participants was 38.4 ± 12.8 years of age. The majority were black, premenopausal, less than 52 years of age, not employed full time, had less than a college degree, made less than $25,000 per year, and were not in a partnered relationship (Table 1).

Table 1.

Socioeconomic characteristics of participants.

Demographic characteristics Percent/mean ± SDa
Age (years)b 38.4 ± 12.8
Race
 Black 144 (66)
 White 75 (34)
Ethnicity
 Hispanic 3 (1)
 Non-Hispanic 216 (99)
Education
 Partial high school or less 9 (6)
 High school graduate or equivalent (GED) 41 (28)
 Partial college/university 38 (26)
 College/university graduate 42 (30)
 Post-graduate/professional degree 15 (10)
Annual Income (USD)
 < $24,999 66 (45)
 $45,000 – 49,999 32 (22)
 $50,000 – 99,999 19 (13)
 >$100,000 8 (6)
 Prefer not to answer 21 (14)
Relationship status
 Single, never married 62 (43)
 Divorced/separated/widowed 21 (14)
 Married/marriage-like relationship 63 (43)
Age
 < 52 years 178 (81)
 ≥ 52 years 41 (19)
Menopausal status
 No 116 (81)
 Yes 28 (19)
Employment status
 Full time (40 hrs./week) 43 (29)
 Part time (17–39 hrs./week) 31 (21)
 Occasional (1–16 hrs./week) 4 (3)
 Full time homemaker 8 (6)
 Student 18 (12)
 Retired 7 (5)
 Disabled 8 (6)
 Unemployed 27 (18)
a

SD: standard deviation.

b

Data are n (%) unless otherwise specified.

Mass mailing was significantly more effective than the media or clinician referrals in the number of women screened (54% vs. 27% vs. 19%), respectively. It was also more effective in the number of subject's enrolled (50% vs 26% vs. 23%), respectively. The proportion of those screened who enrolled (recruitment fraction) was 25%. The recruitment fractions did not differ significantly by recruitment method (mass mailing (23%) vs media (25%) clinician referrals (31%)).

Relative to clinician referral, black women were 13 times as likely to be enrolled through mass mailing as white women (Table 2). There were no statistically significant differences in enrollment of participants according to educational level, annual income, relationship status, age, menopausal status, or employment status and recruitment method.

Table 2.

Multinomial logistic regression for enrollment method.

Variable Mass Mailing Media Clinician Referrala

N αORb (95% CI)c P N αOR (95% CI) P N
Race
Blacks 93 12.5 (3.6, 43.1) <0.001 35 3.8 (1.0, 14.9) 0.06 16
Whites 17 23 35
Educational Level
< College Degree 51 3.2 (1.0, 9.9) 0.05 20 1.3 (0.4, 4.7) 0.66 17
≥ College Degree 16 13 29
Annual Income
< $25,000/year 38 1.9 (0.5, 7.4) 0.34 17 3.5 (0.8, 15.3) 0.10 11
≥ $25,000/year 21 8 30
Relationship Status
Non-partnered 43 1.2 (0.4, 3.9) 0.78 23 2.3 (0.6, 8.5) 0.23 17
Partnered 24 10 29
Age
< 52 years 93 1.3 (0.2, 9.3) 0.77 43 0.5 (0.1, 4.0) 0.50 42
≥ 52 years 17 15 9
Menopausal
Yes 11 0.9 (0.2, 4.6) 0.91 5 0.7 (0.1, 4.3) 0.68 12
No 56 28 32
Employment Status
Full-time 21 1.6 (0.4, 6.1) 0.48 8 2.0 (0.5, 8.3) 0.33 14
Not Full-time 46 25 32
a

Reference group.

b

Odds ratios (αOR) were computed through multinomial logistic regression analysis.

c

CI = confidence interval.

Discussion

We compared the effectiveness and efficiency of four recruitment methods. We found that mass mailing was most effective in screening and enrolling women compared to clinician referral, media, or community outreach. These findings are consistent with one of the largest clinical trials conducted in women, the Women's Health Initiative, where the most effective recruitment strategy was mass mailing, accounting for 67% of total participants enrolled, followed by 14% from newspapers or magazine advertisements.27

Nevertheless, the finding that clinician referral was a less effective recruitment method than mass mailing is somewhat surprising, since this method is commonly used with the assumption that recognition of the study by a patient's clinician would generate a large population of subjects. However, clinicians may be reluctant to refer patients to research studies because it diverts time and resources away from their practice.28 Our study provided no strong evidence of differences in efficiency of the recruitment methods other than the inferiority of community outreach.

We also determined socioeconomic predictors of enrollment for each of the recruitment methods. We found that white women were significantly more likely to be enrolled through clinician referrals and black women through mass mailing. This demographic profile is consistent with research in previous clinical trials in vulvodynia,310,1215 and suggests that clinician referral may not reach the broader population of women with this condition, and that recruitment methods should include mass mailing to maximize diversity in the study cohort.

The fact that mass mailing was an effective recruitment method for enrolling black women is a key finding, as enhancing recruitment and participation in clinical trials among underrepresented groups is a national priority. Although the NIH Revitalization Act of 1993 authorized that minorities be appropriately represented in clinical trials, they continue to have lower enrollment rates in health research when compared to nonminority groups.30

It is noteworthy that community outreach was not an effective recruitment strategy in recruiting black women, despite the fact that it is commonly used, in part, due to perceived distrust among minority populations of the medical community.31 Since this method was ineffective, and may be limited by time commitment of investigators and staff, it is not suggested as a primary method of recruitment in vulvodynia trials.

A strength of our study was the large population of black women who enrolled; however, a major limitation was the inability to determine which recruitment method was most successful in enrolling Hispanic women, where vulvodynia is most prevalent.1618 Difficulties in reaching these women may have been due to unavailability of Spanish-speaking research staff or the geographic location of the research sites. Larger multicenter trials with available translators are necessary to recruit this subgroup of women.

Methodological issues may have influenced results. We used multiple recruitment methods concurrently, so it is difficult to state whether findings would have been similar if they were run independently. It is also possible that the media may have been a more successful recruitment method if television advertising had been used, but because of costs and budgetary constraints, we limited advertising to newspaper ads, websites and radio.

Future research should explore which recruitment methods are most effective in reaching women of diverse ethnicities and races, age groups, and subtypes of vulvodynia and in women with other medical conditions.

Acknowledgments

The authors thank Nancy Phillips, MD and Adrienne Bonham, MD as Co-investigators, Turid M. Dulin, RN at UTHSC and Diane Dawicki, LPN at Rutgers-RWJMS for serving as research nurses, Ian M. Brooks, PhD and Mark E Sakauye at UTHSC for data management, Pavan Balabathula, PhD, Frank P Horton, BS, Laura A. Thoma and Robert J Nolly, MS, DPh at UTHSC for capsaicin preparation, Robert H. Dworkin PhD at URMC as Methods consultant, and Ronald W. Wood PhD at URMC for instrument development. DSMB members: William A. Pulsinelli, MD, PhD at UTHSC, Deanne Taylor, PhD at Rutgers, John Queenan, MD at URMC, Paul Nyirjesy, MD at Drexel University, Diane Hartman, MD, at URMC, Ursula Wesselmann, MD, PhD at the University of Alabama at Birmingham and Sue Fosbre at Rutgers-RWJMS as secretary of DSMB.

Funding This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the Office of Women's Health Research [HD065740]; the University of Tennessee General Clinical Research Center [GCRC]; and Depomed, Inc. who provided gabapentin extended release and matching placebo for the study.

Clinical Trial Registration: ClinicalTrials.gov, www.clinicaltrials.gov, NCT1301001

Footnotes

Declaration of conflicting interest The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

  • 1.Gross CP, Mallory R, Heiat A, et al. Reporting the recruitment process in clinical trials: Who are these patients and how did they get there? Ann Intern Med. 2002;137:10–16. doi: 10.7326/0003-4819-137-1-200207020-00007. [DOI] [PubMed] [Google Scholar]
  • 2.Bornstein J, Goldstein AT, Stockdale CK, et al. 2015 ISSVD, ISSWSH and IPPS consensus terminology and classification of persistent vulvar pain and vulvodynia. Obstet Gynecol. 2016;127:745–751. doi: 10.1097/AOG.0000000000001359. [DOI] [PubMed] [Google Scholar]
  • 3.Petersen CD, Giraldi A, Lundvall L, et al. Botulinum toxin type A—a novel treatment for provoked vestibulodynia? Results from a randomized, placebo controlled, double blinded study. J Sex Med. 2009;6:2523–2537. doi: 10.1111/j.1743-6109.2009.01378.x. [DOI] [PubMed] [Google Scholar]
  • 4.Danielsson I, Torstensson T, Brodda-Jansen G, et al. EMG biofeedback versus topical lidocaine gel: a randomized study for the treatment of women with vulvar vestibulitis. Acta Obstet Gynecol Scan. 2006;85:1360–1367. doi: 10.1080/00016340600883401. [DOI] [PubMed] [Google Scholar]
  • 5.Bornstein J, Zarfati D, Goldik Z, et al. Perineoplasty compared with vestibuloplasty for severe vulvar vestibulitis. Br J Obstet Gynecol. 1995;102:652–655. doi: 10.1111/j.1471-0528.1995.tb11405.x. [DOI] [PubMed] [Google Scholar]
  • 6.Bornstein J, Abramovici H. Combination of subtotal perineoplasty and interferon for the treatment of vulvar vestibulitis. Gynecol Obstet Invest. 1997;44:53–56. doi: 10.1159/000291409. [DOI] [PubMed] [Google Scholar]
  • 7.Bornstein J, Livnat G, Stolar Z, et al. Pure versus complicated vulvar vestibulitis: a randomized trial of fluconazole treatment. Gynecol Obstet Invest. 2000;50:194–197. doi: 10.1159/000010309. [DOI] [PubMed] [Google Scholar]
  • 8.Bornstein J, Tuma R, Farajun Y, et al. Topical nifedipine for the treatment of localized provoked vulvodynia: a placebo-controlled study. J Pain. 2010;11:1403–1409. doi: 10.1016/j.jpain.2010.03.016. [DOI] [PubMed] [Google Scholar]
  • 9.Nyirjesy P, Sobel JD, Weitz MV, et al. Cromolyn cream for recalcitrant idiopathic vulvar vestibulitis: results of a placebo-controlled study. Sex Transm Inf. 2001;77:53–57. doi: 10.1136/sti.77.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Farajun Y, Zarfati D, Abramov L, et al. Enoxaparin treatment for vulvodynia: a randomized controlled trial. Obstet Gynecol. 2012;120:565–572. doi: 10.1097/AOG.0b013e3182657de6. [DOI] [PubMed] [Google Scholar]
  • 11.Delgado-Rodriguez M, Llorca J. Bias. J Epidemiol Commun. 2004;58:635–641. doi: 10.1136/jech.2003.008466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Bergeron S, Binik YM, Khalife S, et al. A randomized comparison of group cognitive-behavioral therapy, surface electromyographic biofeedback, and vestibulectomy in the treatment of dyspareunia resulting from vulvar vestibulitis. Pain. 2001;91:297–306. doi: 10.1016/S0304-3959(00)00449-8. [DOI] [PubMed] [Google Scholar]
  • 13.Masheb RM, Kerns RD, Lozano C, et al. A randomized clinical trial for women with vulvodynia: Cognitive-behavioral therapy vs. supportive psychotherapy. Pain. 2009;141:31–40. doi: 10.1016/j.pain.2008.09.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Schlaeger JM, Xu N, Mejta CL, et al. Acupuncture for the treatment of vulvodynia: a randomized wait-list controlled pilot study. J Sex Med. 2015;12:1019–1027. doi: 10.1111/jsm.12830. [DOI] [PubMed] [Google Scholar]
  • 15.Corsini-Munt S, Bergeron S, Rosen NO, et al. Feasibility and preliminary effectiveness of a novel cognitive-behavioral couple therapy for provoked vestibulodynia: a pilot study. J Sex Med. 2014;11:2515–2527. doi: 10.1111/jsm.12646. [DOI] [PubMed] [Google Scholar]
  • 16.Harlow BL, Kunitz CG, Nguyen RHN, et al. Prevalence of symptoms consistent with a diagnosis of vulvodynia: population-based estimates from 2 geographic regions. Am J Obstet Gynecol. 2014;210:40.e1–8. doi: 10.1016/j.ajog.2013.09.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Reed BD, Harlow SD, Sen A, et al. Prevalence and demographic characteristics of vulvodynia in a population-based sample. Am J Obstet Gynecol. 2012;206:170.e1–9. doi: 10.1016/j.ajog.2011.08.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Reed BD, Legocki LJ, Plegue MA, et al. Factors associated with vulvodynia incidence. Obstet Gynecol. 2014;123:225–231. doi: 10.1097/AOG.0000000000000066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.De Las Nueces D, Hacker K, DiGirolamo A, et al. A systematic review of community-based participatory research to enhance clinical trials in racial and ethnic minority groups. Special Issue: Measuring and analyzing health care disparities. Health Serv Res. 2012;47:1363–1386. doi: 10.1111/j.1475-6773.2012.01386.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Goetsch MF, Lim JY, Caughey AB. Locating pain in breast cancer survivors experiencing dyspareunia: a randomized controlled trial. Obstet Gynecol. 2014;123:1231–1236. doi: 10.1097/AOG.0000000000000283. [DOI] [PubMed] [Google Scholar]
  • 21.UyBico SJ, Pavel S, Gross CP. Recruiting vulnerable populations into research: A systematic review of recruitment interventions. J General Internal Med. 2007;22:852–863. doi: 10.1007/s11606-007-0126-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Friedrich EG., Jr Vulvar vestibulitis syndrome. J Reprod Med. 1987;32:110–114. [PubMed] [Google Scholar]
  • 23.Bergeron S, Binik YM, Khalife S, et al. Vulvar vestibulitis syndrome: reliability of diagnosis and evaluation of current diagnostic criteria. Obstet Gynecol. 2001;98:45–51. doi: 10.1016/s0029-7844(01)01389-8. [DOI] [PubMed] [Google Scholar]
  • 24.Foster DC, Kotok MB, Huang LS, et al. The Tampon Test for vulvodynia research: reliability, construct validity, responsiveness. Obstet Gynecol. 2009;113:825–832. doi: 10.1097/AOG.0b013e31819bda7c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Reed BD, Haefner HK, Harlow SD, et al. Reliability and validity of self-reported symptoms for predicting vulvodynia. Obstet Gynecol. 2006;108:906–913. doi: 10.1097/01.AOG.0000237102.70485.5d. [DOI] [PubMed] [Google Scholar]
  • 26.Hosmer DW, Lemeshow S, Sturdivant RX. Applied Logistic Regression. 3rd ed. John Wiley & Sons, Inc.; Hoboken (NJ): 2013. p. 269. [Google Scholar]
  • 27.Hays J, Hunt JR, Hubbell FA, et al. The Women's Health Initiative recruitment methods and results. Ann Epidemiol. 2003;13(9 Suppl):S18–S77. doi: 10.1016/s1047-2797(03)00042-5. [DOI] [PubMed] [Google Scholar]
  • 28.Rahman S, Majumder MA, Shaban SF, et al. Physician participation in clinical research and trials: Issues and approaches. Adv Med Educ Pract. 2011;2:85–93. doi: 10.2147/AMEP.S14103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.National Institutes of Health [accessed July 2015];Outreach notebook for the inclusion, recruitment and retention of women and minority subjects in clinical research. 2015 http://orwh.od.nih.gov/research/inclusion/pdf/Outreach-Notebook-021315.pdf.
  • 30.National Institutes of Health [Accessed 15 July 2016];NIH Revitalization Act. B: Sec 131–133; 1993. http://orwh.od.nih.gov/about/pdf/NIH-Revitalization-Act-1993.pdf.
  • 31.Corble-Smith G, Thomas S, Williams M, et al. Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med. 1999;14:537–546. doi: 10.1046/j.1525-1497.1999.07048.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES